Table 2—

Baseline characteristics of subjects in the study

GlargineNPH
n367389
Sex (F/M) (%)45/5544/56
Age (years)55 ± 9.556 ± 8.9
Duration of diabetes (years)8.4 ± 5.559.0 ± 5.57
BMI (kg/m2)32.5 ± 4.6432.2 ± 4.80
FPG (mg/dl [mmol/l])198 (11.0) ± 49 (2.71)194 (10.8) ± 47 (2.61)
HbA1c (%)8.61 ± 0.98.56 ± 0.9
Ethnicity (%)
 White8483
 Black1113
 Asian33
 Multiracial11
Hispanic heritage (%)106
Prior therapy (%)
 SU + metformin7174
 SU only1110
 Metformin only87
 SU + TZD65
 Metformin + TZD33
 TZD only<1<1
  • Data are means ± SD, unless otherwise noted. SU, sulfonylurea; TZD, thiazolidinedione.